Curis

Curis

Curis reports advancements in cancer treatment studies By Investing.com

Stocks August 4, 2024

In a recent earnings call, Curis Inc. (NASDAQ:), a biotechnology company specializing in cancer treatments, provided a business update for the second quarter of 2024. President and CEO Jim Dentzer outlined significant progress in the company’s TakeAim Lymphoma and TakeAim Leukemia studies, focusing on the development of their drug emavusertib.…

Trending

USDA approves funds to fight screwworm, may resume Mexico cattle imports this year By Reuters

Ozempic linked to vision loss risk in new study By Investing.com

Only 32 artists have multiple songs that are certified diamond — here they all are

Daring outfits Taylor Swift has worn throughout her career, from see-through dresses to plunging necklines

10 Year-End Tax Planning Strategies That Could Save You Money

Curis reports advancements in cancer treatment studies By Investing.com

Ozempic linked to vision loss risk in new study By Investing.com

Only 32 artists have multiple songs that are certified diamond — here they all are

Daring outfits Taylor Swift has worn throughout her career, from see-through dresses to plunging necklines

10 Year-End Tax Planning Strategies That Could Save You Money

Buyer’s Market Vs. Seller’s Market In Real Estate

Biden administration inks renewed science cooperation deal with China; Republicans cry foul By Reuters

I was in the best shape of my life when I got hit by a car. The debilitating pain during recovery left me emotionally shredded.

We toured Disney’s newest cruise ship. These are its 11 coolest amenities, from a Jungle Cruise lounge to ‘Moana’ and ‘Mulan’ cafés

Subscribe to Updates

Trending

Curis